Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  GW Pharmaceuticals plc       GB0030544687

GW PHARMACEUTICALS PLC
SummaryNewsRatingsCalendarCompany 
Business Summary
GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company is also focused on developing its pharmaceutical product pipelines, which includes Epidiolex for the treatment of Tuberous Sclerosis Complex and RETT Syndrome.

Number of employees : 901 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Novel Therapeutics35.29227.5%395.90127.2% +1021.77%
Other0.1971.3%1.280.4% +547.1%
Sales per region
2019
USD (in Million)%
United States367.62118.1%
Europe21.076.8%
Other5.231.7%
United Kingdom3.251%
Managers and Directors
NameAgeSinceTitle
Justin D. Gover49-Chief Executive Officer & Executive Director
Geoffrey William Guy, Dr.661998Chairman
Christopher John Tovey552012Chief Operating Officer
Scott M. Giacobello502017CFO & Principal Accounting Officer
Volker Knappertz, Dr.552017Chief Medical Officer
James Julian Noble612007Deputy Chairman
Cabot Brown592013Independent Non-Executive Director
Catherine J. Mackey, Dr.642017Independent Non-Executive Director
Alicia Secor582017Independent Non-Executive Director
William Arthur Waldegrave742017Independent Non-Executive Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 374,169,836 370,428,138 99.0% 0 0.0% 99.0%
Shareholders
NameEquities%
Capital Research & Management Co. (Global Investors) 3,732,712 12.0%
Capital Research & Management Co. (World Investors) 2,754,644 8.83%
Franklin Advisers, Inc. 2,223,859 7.13%
Janus Capital Management LLC 2,041,289 6.55%
Canada Pension Plan Investment Board 1,500,000 4.81%
Federated Global Investment Management Corp. 861,744 2.76%
Morgan Stanley Smith Barney LLC (Investment Management) 821,731 2.64%
Scopia Capital Management LP 749,538 2.40%
Consonance Capital Management LP 604,604 1.94%
Victory Capital Management, Inc. (Investment Management) 573,752 1.84%
Company contact information
GW Pharmaceuticals Plc
Sovereign House
Vision Park, Chivers Way
Histon
Cambridge, Cambridgeshire CB24 9BZ

Phone : +44.1223.266800
Fax : +44.1223.235667
Web : http://www.gwpharm.com
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
GW PHARMACEUTICALS PLC17.13%4 232
GILEAD SCIENCES, INC.8.70%79 386
VERTEX PHARMACEUTICALS-4.57%58 652
REGENERON PHARMACEUTICALS7.21%54 665
WUXI APPTEC CO., LTD.6.43%53 924
BEIGENE, LTD.33.52%31 458
GENMAB A/S11.17%29 075
BIONTECH SE24.62%24 461
HUALAN BIOLOGICAL ENGINEERING INC.21.21%14 275
ARGENX SE-4.46%13 219
MYOKARDIA, INC.0.00%11 993
MIRATI THERAPEUTICS, INC.-2.35%10 784
FATE THERAPEUTICS, INC.24.92%10 412
NEUROCRINE BIOSCIENCES, INC.12.35%10 061
ULTRAGENYX PHARMACEUTICAL INC.-0.33%9 128
DENALI THERAPEUTICS INC.-12.81%8 758
ASCENDIS PHARMA A/S-5.31%8 529
ARROWHEAD PHARMACEUTICALS, INC.5.23%8 297
KODIAK SCIENCES INC.7.92%7 986
ACCELERON PHARMA INC.-1.37%7 603
EXELIXIS, INC.18.21%7 361
Connections : GW Pharmaceuticals plc
Categories
Free services
Mobile App
SOLUTIONS
About
Stock Market Quotes Interactive brokers The best of tweets Stock Market News Börse: Aktien, Kurse und Nachrichten
Copyright © 2021 Surperformance. All rights reserved. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ